review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Osamu Yokosuka | |
Hitoshi Maruyama | |||
Masaharu Yoshikawa | |||
P2860 | cites work | Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 |
Analysis of clinical effect of high-intensity focused ultrasound on liver cancer. | Q30393153 | ||
Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. | Q30542673 | ||
Three-dimensional ultrasound imaging | Q33673327 | ||
Epidemiology of primary liver cancer | Q33750533 | ||
Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection | Q33797552 | ||
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications | Q34038386 | ||
Vascularity of liver tumours and recent advances in doppler ultrasound | Q34231496 | ||
Ultrasound of focal liver lesions | Q34340865 | ||
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection | Q34503100 | ||
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. | Q34503653 | ||
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection | Q34533894 | ||
Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. | Q34535655 | ||
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance | Q34546781 | ||
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma | Q34558527 | ||
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis | Q34571059 | ||
3D CT versus axial helical CT versus conventional tomography in the classification of acetabular fractures: a ROC analysis | Q34615382 | ||
Color Doppler flow imaging of liver tumors | Q34629023 | ||
Hepatocellular carcinoma: Recent progress | Q35227361 | ||
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. | Q35362684 | ||
High intensity focused ultrasound: surgery of the future? | Q35538597 | ||
Screening for hepatocellular carcinoma in cirrhosis | Q35594964 | ||
Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study | Q35596794 | ||
Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience | Q35648671 | ||
Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens | Q35895284 | ||
Preneoplastic lesions in human hepatocarcinogenesis | Q36033377 | ||
Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization | Q36109501 | ||
Role of real time 3D echocardiography in evaluating the left ventricle | Q36347275 | ||
Color Doppler flow imaging | Q37318022 | ||
Color Doppler imaging: principles, limitations, and artifacts | Q37952202 | ||
Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles | Q39227229 | ||
Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population | Q39371266 | ||
Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. | Q39434111 | ||
Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. | Q39691106 | ||
Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy | Q40715647 | ||
Three-dimensional sonographic reconstruction: techniques and diagnostic applications | Q40846477 | ||
Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma | Q42031483 | ||
Hepatic tumors: US contrast enhancement with CO2 microbubbles | Q43639888 | ||
CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US. | Q43945414 | ||
Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes | Q73843525 | ||
Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study | Q73901364 | ||
Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation | Q73999732 | ||
Screening for hepatocellular carcinoma | Q74027220 | ||
Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading | Q74071306 | ||
CT-guided treatment of ultrasonically invisible hepatocellular carcinoma | Q74194667 | ||
Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT | Q74230363 | ||
Stimulated acoustic emission in liver parenchyma with Levovist | Q74282334 | ||
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis | Q74489428 | ||
Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein | Q74614557 | ||
Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography | Q77499401 | ||
Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US | Q77528869 | ||
Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience | Q77824577 | ||
Percutaneous gadolinium injection under MR guidance to mark target for CT-guided radiofrequency ablation | Q77878275 | ||
Hepatic sonography: comparison of tissue harmonic and standard sonography techniques | Q77972642 | ||
Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver | Q78397096 | ||
Ring-shaped appearance in liver-specific image with Levovist: a characteristic enhancement pattern for hypervascular benign nodule in the liver of heavy drinkers | Q79910322 | ||
Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions | Q81041133 | ||
Vascular flow patterns of hepatic tumors in contrast-enhanced 3-dimensional fusion ultrasonography using plane shift and opacity control modes | Q81191063 | ||
Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis | Q81569983 | ||
Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions | Q81631952 | ||
Hepatocellular carcinoma | Q93930900 | ||
Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results | Q73141300 | ||
Tissue harmonic imaging | Q73284877 | ||
Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging | Q73364109 | ||
CT fluoroscopy: technique and utility in guiding biopsies of transiently enhancing hepatic masses | Q73397847 | ||
Limitations of the histopathological diagnosis and prognostic assessment of hepatocellular carcinoma | Q73511026 | ||
Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings | Q73519491 | ||
Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma | Q73556874 | ||
Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group | Q73674282 | ||
Screening for hepatocellular carcinoma in patients with advanced cirrhosis | Q44477761 | ||
Different behaviors of microbubbles in the liver: time-related quantitative analysis of two ultrasound contrast agents, Levovist and Definity | Q45098746 | ||
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America | Q45302951 | ||
CT Evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease | Q45414223 | ||
Multiple hypervascular liver nodules in a heavy drinker of alcohol | Q46457457 | ||
Real-time three-dimensional fetal echocardiography using matrix probe | Q46500677 | ||
Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation | Q46591334 | ||
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma | Q46702705 | ||
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival | Q46743120 | ||
Three-dimensional ultrasonic angiography using power-mode Doppler | Q48524113 | ||
High-intensity focused ultrasound for the treatment of liver tumours | Q50250410 | ||
Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases. | Q50612137 | ||
Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. | Q50871750 | ||
Efficacy of a surveillance program for early detection of hepatocellular carcinoma. | Q51013459 | ||
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. | Q51033885 | ||
Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. | Q52412386 | ||
Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients | Q52859808 | ||
Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. | Q52978039 | ||
Correlation between dynamic computed tomographic and histopathological findings in the diagnosis of small hepatocellular carcinoma. | Q53362935 | ||
Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent. | Q53477858 | ||
Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation. | Q53519828 | ||
Clinical utility of three-dimensional US. | Q53527113 | ||
Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. | Q53606213 | ||
Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. | Q53646554 | ||
Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. | Q53649487 | ||
Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. | Q53658624 | ||
Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. | Q53660056 | ||
Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival | Q57001479 | ||
Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma | Q58034569 | ||
Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors | Q61737197 | ||
Successful Opacification of the Left Heart Chambers on Echocardiographic Examination after Intravenous Injection of a New Saccharide Based Contrast Agent | Q61808205 | ||
Color flow Doppler characterization of focal hepatic lesions | Q67506812 | ||
Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival | Q67518277 | ||
The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients | Q67661410 | ||
Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles | Q67915123 | ||
Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients | Q68080989 | ||
Focal liver masses: differential diagnosis with pulsed Doppler US | Q70189298 | ||
Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging | Q70604665 | ||
Three-dimensional colour Doppler imaging | Q70775397 | ||
Ultrasonically guided percutaneous contrast medium injection and aspiration biopsy using a renal-time puncture transducer | Q71223758 | ||
Echocardiography of the Normal and Diseased Aortic Valve | Q71436406 | ||
Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode | Q71511285 | ||
Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver | Q71650810 | ||
Terminology for hepatic allograft rejection. International Working Party | Q71958842 | ||
Vascular imaging with a three-dimensional power Doppler system | Q71984835 | ||
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein | Q72082162 | ||
Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US | Q72260941 | ||
Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound | Q73110027 | ||
CT fluoroscopy-assisted needle puncture and ethanol injection for hepatocellular carcinoma: a preliminary study | Q73131371 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 1710-1719 | |
P577 | publication date | 2008-03-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Current role of ultrasound for the management of hepatocellular carcinoma | |
P478 | volume | 14 |